Literature DB >> 10673333

An integrated genetic linkage map with 1,137 markers constructed from five F2 crosses of autoimmune disease-prone and -resistant inbred rat strains.

S V Dracheva1, E F Remmers, S Chen, L Chang, P S Gulko, Y Kawahito, R E Longman, J Wang, Y Du, J Shepard, L Ge, B Joe, S Kotake, J L Salstrom, T Furuya, J Hoffman, G W Cannon, M M Griffiths, R L Wilder.   

Abstract

The rat (Rattus norvegicus) is an important experimental model for many human diseases including arthritis, diabetes, and other autoimmune and chronic inflammatory diseases. The rat genetic linkage map, however, is less well developed than those of mouse and human. Integrated rat genetic linkage maps have been previously reported by Pravenec et al. (1996, Mamm. Genome 7: 117-127) (500 markers mapped in one cross), Bihoreau et al. (1997, Genome Res. 7: 434-440) (767 markers mapped in three crosses), Wei et al. (1998, Mamm. Genome 9: 1002-1007) (562 markers mapped in two crosses), Brown et al. (1998, Mamm. Genome 9: 521-530) (678 markers mapped in four crosses), and Nordquist et al. (1999, Rat Genome 5: 15-20) (330 markers mapped in two crosses). The densest linkage map combined with a radiation hybrid map, reported by Steen et al. (1999, Genome Res. 9: AP1-AP8), includes 4736 markers mapped in two crosses. Here, we present an integrated linkage map with 1137 markers. We have constructed this map by genotyping F2 progeny of five crosses: F344/NHsd x LEW/NHsd (673 markers), DA/Bkl x F344/NHsd (531 markers), BN/SsN x LEW/N (714 markers), DA/Bkl x BN/SsNHsd (194 markers), and DA/Bkl x ACI/SegHsd (245 markers). These inbred rat strains vary in susceptibility/resistance to multiple autoimmune diseases and are used extensively for many types of investigation. The integrated map includes 360 loci mapped in three or more crosses. The map contains 196 new SSLP markers developed by our group, as well as many SSLP markers developed by other groups. Two hundred forty genes are incorporated in the map. This integrated map should allow comparison of rat genetic maps from different groups and thereby facilitate genetic studies of rat autoimmune and related disease models. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673333     DOI: 10.1006/geno.1999.6074

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  5 in total

1.  Adjusted P values for genome-wide scans.

Authors:  Theodore C Lystig
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

2.  Integrative genomics: in silico coupling of rat physiology and complex traits with mouse and human data.

Authors:  Simon N Twigger; Jeff Nie; Victor Ruotti; Jiaming Yu; Dan Chen; Dawei Li; Jed Mathis; Vijay Narayanasamy; Gopal R Gopinath; Dean Pasko; Mary Shimoyama; Norberto De La Cruz; Susan Bromberg; Anne E Kwitek; Howard J Jacob; Peter J Tonellato
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

3.  Identification of candidate disease genes by EST alignments, synteny, and expression and verification of Ensembl genes on rat chromosome 1q43-54.

Authors:  Ursula Vitt; Darryl Gietzen; Kristian Stevens; Jim Wingrove; Shanya Becha; Sean Bulloch; John Burrill; Narinder Chawla; Jennifer Chien; Matthew Crawford; Craig Ison; Liam Kearney; Mary Kwong; Joe Park; Jennifer Policky; Mark Weiler; Renee White; Yuming Xu; Sue Daniels; Howard Jacob; Michael I Jensen-Seaman; Jozef Lazar; Laura Stuve; Jeanette Schmidt
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

4.  Electrophoretic techniques applied to the detection and analysis of the human microsatellite DG10s478.

Authors:  Clara Y Taylor; Isabel A Guillén; Marcelo Nazabal; Julio R Fernández; José A Silva
Journal:  J Biomol Tech       Date:  2007-12

5.  Comparative recombination rates in the rat, mouse, and human genomes.

Authors:  Michael I Jensen-Seaman; Terrence S Furey; Bret A Payseur; Yontao Lu; Krishna M Roskin; Chin-Fu Chen; Michael A Thomas; David Haussler; Howard J Jacob
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.